细胞骨架作用剂抗青光眼的研究进展

细胞骨架与细胞的各种活动和功能密切相关。在细胞外基质的参与下，细胞骨架调控着房水流出通道的解剖学构架，从而影响小梁网的滤过功能。研究表明，细胞骨架作用剂，如利尿酸、latrunculins、细胞松弛素、某些蛋白激酶抑制剂（H-7、HA1077、Y-27632）、blebbistatin、他汀类药物和BDM均可增加房水流出易度。目前的研究正在致力于探讨细胞骨架作用剂调节房水流出的机制。种种迹象表明，细胞骨架作用剂有可能成为有潜力的抗青光眼药物。

Current research of cytoskeletal agents in the application for glaucoma therapy

Cytoskeleton is responsible for numerous cellular processes. Together with the extracellular matrix,cytoskeleton provides a structural framework for the outflow pathway and thus influences the filtering capacity of the trabecular meshwork. Interestingly, cytoskeletal agents such as ECA, latrunculins, cytochalasin, H-7, HAl077, Y-27632, blebbistatin, cholesterollowering statins and BDM have all been shown to influence aqueous humor outflow. A lot of studies have focused on understanding how the cytoskeletal agents regulate the aqueous humor outflow. The results from all of experiment suggest that cytoskeletal agents would possess therapeutic potential in the treatmentof glaucoma.